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Abstract 
Purpose: Studies on active and passive tobacco smoking and breast cancer have found inconsistent results. 
Methods: A meta-analysis of observational studies on tobacco smoking and breast cancer occurrence was 
conducted based on systematic searches for studies with retrospective (case-control) and prospective (cohort) 
designs. Eligible studies were identified and relative risk measurements were extracted for active and passive 
tobacco exposures. Random effects meta-analyses were used to compute summary relative risks (SRR). 
Heterogeneity of results between studies was evaluated using the (I2) statistics. 
Results: For ever active smoking, in 27 prospective studies, the SRR for breast cancer was 1.10 (95% CI [1.09-
1.12]) with no heterogeneity (I2 = 0%). In 44 retrospective studies, the SRR was 1.08 (95% CI [1.02-1.14]) with 
high heterogeneity (I2 = 59%). SRRs for current active smoking were 1.13 (95%CI [1.09-1.17]) in 27 prospective 
studies and 1.08 (95%CI [0.97-1.20]) in 22 retrospective studies. The results were stable across different subgroup 
analyses, notably pre/post-menopause, alcohol consumption adjustments, including/excluding passive smokers 
from the referent group. For ever passive smoking, in 11 prospective studies, the SRR for breast cancer was 1.07 
(95% CI [1.02-1.13]) with no heterogeneity (I2 = 1%). In 20 retrospective studies, the SRR was 1.30 (95% CI 
[1.10-1.54]) with high heterogeneity (I2 = 74%). Too few prospective studies were available for meaningful sub-
group analyses. 
Conclusion: There is consistent evidence for a moderate increase in the risk of breast cancer in women who smoke 
tobacco. The evidence for a moderate increase in risk with passive smoking is more substantial than a few years 
ago. 
Keywords: breast cancer; environmental tobacco smoke; smoking; meta-analysis 
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INTRODUCTION 
Breast cancer is the most common cancer in women in the world, representing one quarter of all cancers diagnosed 
in women in 2012 [15]. Among the lifestyle risk factors for breast cancer, Danaei et al.[11] found that 21% of 
breast cancer deaths are attributable to alcohol consumption, overweight and obesity, and lack of physical activity. 
Observational studies on active or passive smoking and breast cancer, as well as meta-analyses and reviews have 
reached a wide range of conclusions, from an unlikely association to suggestion of a causal association [9, 21, 25, 
32, 36, 43]7KH6XUJHRQ*HQHUDO¶V5HSRUW [42] is the most recent large review on the topic that reviewed the 
literature until 2012, finding a small but significant increased risk of breast cancer for active smokers and 
suggesting a possible association between passive smoking and breast cancer in premenopausal women. 
The aim of this study was to systematically review and perform meta-analyses on the relationship between active 
and passive tobacco exposures and breast cancer occurrence, based on an exhaustive search of observational 
studies published up to March 2015. 
METHODS 
Studies published up to March 2015 were identified through a search of PUBMED and Web of Science databases, 
ZLWK WKH NH\ZRUGV ³VPRNLQJ´ ³WREDFFR VPRNH SROOXWLRQ´ ³WREDFFR XVH´ ³WREDFFR SURGXFWV´ ³EUHDVW
QHRSODVPV´ XVLQJ ERWK 0H6+ WHUPV IRU WKH 38%0(' VHDUFK DQG RWKHU SRVVLEOH V\QRQ\PV HJ ³EUHDVW
FDUFLQRPD´$GGLWLRQDOUHFords were manually identified searching the references of published articles, reviews 
and previous meta-analyses. 
Study eligibility criteria 
Literature searches focused on prospective (cohorts, nested case controls, case-cohorts) and retrospective (case-
controls) observational studies. Ecological and cross-sectional studies were excluded. Case control studies were 
excluded if i) not enough information was available regarding cases and controls selection; ii) the control selection 
was likely to be biased (e.g., low response rate, controls unrepresentative of the cases); iii) the breast cancer cases 
were prevalent and not incident. Breast cancer cases were considered incident if the time between breast cancer 
diagnosis and the interview to ascertain tobacco exposure data was at most 6 months. Active smoking exposure 
had to be reported as ever, former or current smoking. Passive smoking exposure was extracted as having ever 
been exposed to second-hand smoke during lifetime or the most comprehensive indicator of passive smoking 
exposure. 
Studies had to report an estimate for the relative risk of incident invasive breast cancer for those exposed to tobacco 
(actively or passively) compared to those never exposed (actively or passively, respectively) or sufficient data to 
compute a risk estimate. Studies on mortality, in situ carcinoma, or on patients with previously existing breast 
cancer were excluded. 
Data extraction 
Data on study and population characteristics, outcomes, exposures, risk estimates, and confidence intervals were 
extracted, with verification by a second reviewer. 
When risk parameters were reported by sub-group, the relative risk and 95% CI for the entire study were computed 
using a fixed effects meta-analysis. If risk parameters were reported according to the same referent category, the 
method proposed by Greenland et al.[17] for computing a relative risk and 95% CI for the entire study was used. 
When risk parameters were not reported, the article was searched for data allowing the calculation of unadjusted 
odds ratios (OR) and relative risks.  
Statistical analyses 
No distinction was made between various risk parameters (odds ratio, risk ratio, rate ratio, relative risk). The risk 
parameters and their corresponding variances were log transformed. Summary relative risks (SRR) were computed 
using random effect meta-analysis models [44]. The between-study variance was computed using a restricted 
maximum likelihood estimator [45] and confidence intervals were calculated using the weighted variance method 
[19, 40].  
Heterogeneity of effects across studies was evaluated using the I2statistic, which represents the proportion of total 
variation in the estimates of effects that is due to heterogeneity between study results rather than to chance [20]. 
Subgroup meta-analyses were done to explore possible sources of heterogeneity. Publication bias was investigated 
using three tests [3, 14, 30] and visual assessment of funnel plots. Sensitivity analyses were carried out to assess 
WKHLPSDFWRIHDFKLQGLYLGXDOVWXG\RQWKHVXPPDU\ULVNHVWLPDWHWKURXJKWKH³OHDYH-one-RXW´PHWKRG 
To investigate the evolution of the knowledge on the association between active or passive smoking and breast 
cancer, cumulative temporal meta-analyses were conducted by including studies progressively by year of 
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publication. In this procedure, the summary relative risk and its confidence interval is re-calculated each time that 
a more recent study is included in the group of studies subjected to the meta-analysis.  
A dose-response meta-analysis was carried out for the association between the duration of ever active smoking 
and breast cancer risk using the method described by Greenland et al. [17]. This method requires that data be 
available for the number of cases, person-years, relative risk estimates and their variances for at least three 
quantitative exposure categories. For articles lacking information on either the person-years or the number of cases 
per exposure category, but reporting the total number of cases and person-years, the missing data was estimated 
[2]. Durations of smoking reported in categories were transformed in continuous variables calculated as the 
average of the upper and lower bounds of the categories. When the highest category was open-ended, the duration 
assigned to that category was estimated as the value of the upper bound multiplied by 1.2. For the dose-response 
meta-analysis, a linear model was used to estimate the increment in relative risk associated with each additional 
year of ever active smoking. 
All statistical analyses were done using the R 3.1.3 software. 
RESULTS 
The literature search returned 1639 articles, and 51 additional articles were identified through references search 
(Figure 1). The systematic screening of titles and of abstracts led to the exclusion of 1416 articles. 274 articles 
were reviewed full-text. One hundred eighty-eight articles did not meet eligibility criteria. A final set of 86 articles 
related to independent studies were selected for inclusion in the meta-analysis. Seventy-five studies (31 
prospective, 44 case-controls) investigated the association between active smoking and breast cancer risk, and 31 
studies (11 prospective and 20 retrospective) investigated the association between exposure to passive smoking 
and breast cancer incidence (some studies reported data on both types of exposure). The full list of articles with 
their main characteristics and tobacco smoking data that were reported are summarized in the Supplementary 
material, Table S1. 
Four separate meta-analyses were done comparing ever, or former, or current active smoking exposure ± vs. never 
active smokers, and exposure of never smokers to second-hand smoking vs. absence of exposure to second-hand 
smoking . The summary relative risks (SRR) and their confidence intervals are summarized in Table 1. Forest 
plots for ever active or passive smoking in all studies are displayed in Figure 2 and Figure 3.  
For active smoking, there were more breast cancer cases in prospective than in retrospective studies (Table 1). 
Results of meta-analyses were indicative of statistically significant moderate increased risks of breast cancer 
associated with ever, current and former active tobacco smoking. The highest SRR of 1.13 (95% CI: 1.09-1.17) 
was found for current active smoking in prospective studies. The heterogeneity of results between studies was 
more manifest for retrospective designs. For all but one of these analyses, all three publication bias tests indicated 
no evidence of publication bias for a cut-off p-value of 0.1. For former active smoking among prospective studies, 
the Egger test suggested the presence of publication bias, however the Begg and Macaskill tests did not. The leave-
one sensitivity analysis did not identify any one study that strongly influenced the results. 
In the temporal cumulative meta-analysis (Figure S1), it is apparent that the association between ever smoking and 
breast cancer was already present and statistically significant in 1992, with a SRR of 1.10. This SRR remained at 
around 1.10 since then, with a progressive narrowing of the confidence interval due to the accumulation of breast 
cancer cases. In prospective studies, the increased summary relative risk is manifest since the first six studies were 
SXEOLVKHGLQWKHHDUO\¶V)LJXUH6  
Because heterogeneity of results was high in retrospective studies, stratified analyses were performed for 
prospective studies only (Table 2). A summary relative risk estimate (SRR) for ever active smoking of about 1.10 
was consistently retrieved in studies done in North America and in Europe, in pre or in post-menopausal women, 
and in studies that adjusted or did not adjust for alcohol consumption. A meta-analysis of five studies that reported 
risk estimates using never active nor passive smokers as the referent group, obtained a SRR of 1.13 (95% CI [1.04; 
1.22]). In contrast, when never active, but ever passive smokers was used as the referent group, a similar SRR of 
1.10 (95% CI [1.09; 1.12]) was obtained. Only three studies examined the smoking-breast cancer association in 
women who never drink alcohol. The small number of studies and the overall number of cases they included 
(5947), precluded a meaningful analysis in this subgroup. 
Results for subgroup analyses for current and former active smoking were similar to those for ever active smoking, 
although SRRs were slightly greater for current active smoking (data not shown).  
Results of meta-analyses were indicative of statistically significant moderate increased risks of breast cancer 
associated with exposure to second-hand tobacco smoke (Table 1). The heterogeneity of results between studies 
was confined to retrospective designs. The presence of publication bias was unlikely. The leave-one sensitivity 
analysis did not identify any one study that strongly influenced the results. 
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In the temporal cumulative meta-analysis (Figure S3), the association between passive smoking and breast cancer 
emerged in 2009, after which the SRR continued to increase while the confidence interval narrowed. In prospective 
studies, it is only when the most recent study published in 2014 was included in the meta-analysis that the SRR 
became significant (Figure S4).  
Because heterogeneity of results was high in retrospective studies, stratified analyses for prospective studies only 
were performed (Table 3), but these analyses were hampered by the small number of studies that reported stratified 
relative risks.  
Data of 12 prospective studies allowed to examine the relationship between the duration of ever smoking and the 
risk of breast cancer (Figures 4 and 5). Assuming a linear dose-UHVSRQVH UHODWLRQVKLS WKH VORSH SDUDPHWHU ȕ
provides a quantitative estimate of the incremental increase in the risk of breast cancer associated with each 
additional year of active smoking.  
The summary slope estimate was 1.005 (95% CI [1.003; 1.007]), indicating that with every additional year of 
smoking the relative risk of breast cancer incidence is multiplied by 1.005 (Figure 4). As a consequence, the risk 
of breast cancer in women who smoke during 10, 20 or 30 years is increased by 5, 10, and 16%, respectively.  
A plot of breast cancer risk against smoking duration shows that the dose-response relationship was quite 
consistent in larger studies [4, 8, 10, 29, 35, 47]. In contrast, the relationship was usually erratic in smaller studies 
[1, 7, 16, 27, 31, 38], which contributed to most of the heterogeneity of 65% between results of individual studies 
(Figure 4). Similar results were obtained (based on 11 studies) when pack-years of smoking of ever actively 
smoking were used as the exposure measure (see Supplementary material Figures S5 and S6). 
Nine prospective studies reported the relative risk of breast cancer in function of age at smoking initiation. In order 
to compare the relative risks for smoking initiation before and after 20 years old, two separate random meta-
analyses were computed, one for each category. The summary relative risks were both indicative of a positive 
significant association between ever active smoking (with initiation before or after 20 years old) and breast cancer, 
with a point estimate greater for smoking initiation before 20 years old (SRR=1.11 (95% CI [1.07; 1.15]) vs 
SRR=1.07 (95% CI [1.05; 1.10])) (see Supplementary material Figures S7 and S8). Although for this analysis ever 
smokers (with initiation before or after 20 years old) were not separated into former or current smokers, this finding 
would be consistent with an increased risk of breast cancer with longer smoking duration. 
DISCUSSION 
The results of the present meta-analysis provide evidence that active cigarette smoking would be associated with 
a moderate, statistically significant increased risk of breast cancer. Both retrospective and prospective 
observational designs led to the same conclusion. The summary relative risk estimates have remained remarkably 
stable over time, and the accumulation of studies has steadily reduced the variance of estimated risks. The 
likelihood of an association is further supported by the quasi absence of heterogeneity in results of prospective 
studies and by the stability of results across different subgroups, notably in pre-menopausal and post-menopausal 
women, after adjustment for alcohol consumption, and when passive smokers were excluded from the referent 
group.  
Exposure to environmental tobacco smoke also seems associated with a moderately increased risk of breast cancer. 
However, results for passive smoking are more delicate to interpret because of the difficulty to assess exposure to 
second-hand smoking exposures, and of the relatively small number of available studies. Summary relative risk 
estimates have increased over time, and it is only after 2008 that a statistically significant elevated risk has 
emerged.  
One strength of the present meta-analysis is the inclusion of several recently published observational studies, 
updating the previously published reviews, and the inclusion of older but eligible studies. For both active and 
passive smoking, summary relative risks estimates have remained quite stable over time, and the accumulation of 
studies has steadily reduced the variance of estimated risks.  
Observational epidemiologic studies have their limitations. Case-control studies collect the information 
retrospectively, have no follow-up and can be prone to information and selection bias. Prospective studies are less 
likely to suffer from these biases, however the exposure is often measured only at the baseline, with no information 
on the changes in exposure that arise over the course of the follow-up period, leading to possible exposure 
misclassification. For active smokers, residual confounding is still possible even after adjusting for alcohol 
consumption. The subgroup analysis among never drinkers lacked sufficient power, being based on only three 
studies, and further studies in never drinkers are recommended. 
Some subgroup analyses were unfeasible because of the limited number of available data. For instance, only few 
data were found for Asia, none were found for Central and South America, no data was found for low income 
countries. Only three prospective studies gave results stratified by ER/PR tumour subtype [12, 29, 34]. The small 
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 6 
number of prospective studies on passive smoking and breast cancer precluded sub-group analyses having 
sufficient statistical power.  
Active smoking 
Alcohol is a known risk factor for breast cancer [13, 18], and it has been shown to be positively correlated with 
smoking [33]. The Collaborative Group on hormonal factors [18] analysed the association between alcohol, 
tobacco and breast cancer risk, using individual data from 53 observational studies. They restricted their analysis 
on the effect of tobacco to only never drinking women and concluded that smoking was not associated with breast 
cancer for never drinking women. The Collaborative Group [18] also considered all women regardless of alcohol 
consumption, and the relative risk of breast cancer and active smoking was estimated at 1.09 (95% CI [1.05; 1.13]) 
unadjusted for alcohol and 1.05 (95% CI [1.01; 1.09]) adjusting for alcohol, which is consistent with the results of 
the current study. 
In 2010, the International Agency for Research on Cancer (IARC) published a monograph on carcinogenic risks 
[22] and found a positive association between tobacco smoking and breast cancer, based on reviewed literature up 
to 2008. They reported that most cohort studies found an association between longer duration of smoking and 
greater risk of breast cancer, and that no statistically significant differences were observed in function of age at 
smoking initiation. The evidence at the time was considered as inconclusive regarding the association with 
menopausal status. The evidence included in the present meta-analysis was consistent with the previous findings 
regarding smoking duration and age at initiation and subgroup meta-analyses indicated that ever active smokers 
are associated with an increased risk of breast cancer, regardless of menopausal status. 
7KH6XUJHRQ*HQHUDO¶V5HSRUW [42] investigated the association between smoking and breast cancer risk 
based on cohort studies published before 2012 and case-control studies published from 2000 to 2011. They 
concluded that ever active smoking increases the relative risk of breast cancer by D³VWDWLVWLFDOO\VLJQLILFDQWDYHUDJH
RI´6L[VWXGLHVLQFOXGHGLQWKH6XUJHRQ*HQHUDO¶V5HSRUWZHUHH[FOXGHGIURPWKHSUHVHQWDQDO\VLVRQWKHEDVLV
of prevalent cases [6, 26, 37, 39, 41, 48]. The present meta-analysis also includes 13 more recent studies, published 
between 2011 and 2015, and 35 older studies published between 1984 and 2010. The findings of the present 
updated meta-analysis, based on a larger sample of studies, UHLQIRUFHWKHFRQFOXVLRQVRIWKH6XUJHRQ*HQHUDO¶V
Report [42]: i) moderate, but statistically significant average increase of the relative risk of breast cancer incidence 
for active ever/former/current smokers; ii) dose-response relationship between active smoking intensity and 
duration, and breast cancer risk. The Surgeon General¶V 5HSRUW [42] concluded that the association between 
smoking, menopausal status and breast cancer was uncertain. The present study found that the menopausal status 
does not modify the association between active smoking and breast cancer. 
It has been argued that the presence of passive smokers in the referent category could obscure or diminish the 
association between active smoking and breast cancer risk, especially if passive smoking is also associated with 
the risk of developing breast cancer [23, 24, 46]. The results of this meta-analysis were not affected by considering 
only prospective studies that excluded passive smokers from the referent group, showing a moderate, but 
statistically significant, risk of breast cancer in both cases (passive smokers included or excluded from the referent 
group), with the heterogeneity among results remaining low. 
Passive smoking 
In 2010, The IARC monograph [22] reviewed the literature on breast cancer and environmental tobacco smoke 
and found that the evidence was inconsistent. However, the IARC did not perform meta-analyses. The 2014 
6XUJHRQ*HQHUDO¶V5HSRUW [42] performed meta-analyses of articles published before 2012. The report concluded, 
that studies on the association between passive smoking and breast cancer risk had obtained inconsistent results, 
with a small increased risk on average that is highly sensitive to study design. Compared to the Surgeon GeneUDO¶V
report, five studies were excluded because they were considered to include prevalent cases [26, 28, 39, 41, 48] and 
ILYHROGHUVWXGLHVZHUHLQFOXGHGWKDWZHUHQRWFRQVLGHUHGE\WKH6XUJHRQ*HQHUDO¶VUHSRUW,QDGGLWLRQGDWDRIRQH
cohort study have been updated [12], seven new retrospective studies and one cohort study have been published 
from 2011 to 2015. Although the number of prospective studies remains too small to conduct meaningful subgroup 
analyses, the overall summary estimate of the relative risk of breast cancer indicated a moderate, statistically 
VLJQLILFDQWLQFUHDVHIRUSDVVLYHVPRNHUVZLWKYHU\OLWWOHKHWHURJHQHLW\DPRQJWKHSURVSHFWLYHFRKRUWV¶UHVXOWV 
Biological Plausibility 
A considerable literature documents the deleterious and carcinogenic effects of tobacco smoking [5, 
22].concentrations of toxic chemicals are several times higher in side-stream smoke (the smoke produced by an 
idling cigarette) compared to mainstream smoke (the smoke directly inhaled through the cigarette by an active 
smoker) [9]. Exposure to environmental tobacco smoke as well as active cigarette smoking seem therefore 
biologically plausible etiological factors for breast cancer incidence. 
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Conclusions 
As time passes, the evidence accumulates for considering that active tobacco smoking is associated with a modest, 
but real increase in the risk of breast cancer. The consistency of findings, the low heterogeneity of results of 
prospective studies, the dose-response found in prospective studies, the permanent higher risk since the first studies 
done on the topic, and the absence of influence of major confounders on associations are all indicating that the 
relationship would be causal. For passive smoking also, the evidence for a modest but real association with breast 
cancer strengthens with the accumulation of data. In this respect, public health policies should inform women 
about the risk of breast cancer associated with both active and passive smoking.  
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Tables 
Table 1 Summary of meta-analyses results, stratified by studies design and types of exposures 
Meta-analysis Number 
of studies 
Studies 
design 
Total 
number of 
cases 
Summary 
relative risk 
Confidence 
interval 
Heterogeneity 
I2 
Active smoking exposure and breast cancer risk  
Ever active smoking  71 P & R 125251 1.09 1.06 ± 1.12 46 % 
Ever active smoking  27 P 68440 1.10 1.09 ± 1.12 0 % 
Ever active smoking  44 R 56811 1.08 1.02 ± 1.14 59 % 
Current active 
smoking 49 P & R 103893 1.11 1.06 ± 1.16 56 % 
Current active 
smoking  27 P 63087 1.13 1.09 ± 1.17 35 % 
Current active 
smoking  22 R 40806 1.08 0.97 ± 1.20 69 % 
Former active 
smoking  49 P & R 103774 1.09 1.06 ± 1.12 37 % 
Former active 
smoking  27 P 62968 1.09 1.06 ± 1.12 25 % 
Former active 
smoking  22 R 40806 1.09 1.02 ± 1.16 49 % 
Passive smoking exposure and breast cancer risk  
Ever passive 
smoking  31 P & R 34715 1.20 1.07 ± 1.33 67 % 
Ever passive 
smoking  11 P 18022 1.07 1.02 ± 1.13 1 % 
Ever passive 
smoking  20 R 16693 1.30 1.10 ± 1.54 74 % 
P = prospective design and R = retrospective design 
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Table 2 Subgroup analyses among prospective studies investigating the association between ever actively 
smoking and breast cancer risk 
Subgroup No. of 
studies SRR 95% CI I
2(%) 
Begg 
(p-value) 
Egger 
(p-value) 
Macaskill 
(p-value) 
European 9 1.11 1.06 ± 1.15 27[0;66] 0.10(0.92) 1.58(0.49) -0.32(0.76) 
Asian 3 1.20 0.50 ± 2.90 32[0;93] 1.04(0.3) -3.28(0.62) 0(1) 
North American 16 1.11 1.09 - 1.13 0[0;29] 0.14(0.89) 1.09(0.23) -2.60(0.02) 
Post-menopausal 10 1.10 1.07 ± 1.13 0[0;40] 0.18(0.86) -0.84(0.21) -0.05(0.96) 
Pre-menopausal 6 1.11 1.00 ± 1.25 49[0;80] 0.75(0.45) 0.38(0.57) -0.40(0.71) 
Adjusted for alcohol 16 1.09 1.07 ± 1.12 0[0;48] 0.05(0.96) 1.35(0.15) -2.56(0.02) 
Not adjusted for alcohol 11 1.13 1.10 ± 1.16 0[0;27] 0.16(0.88) -1.26(0.08) 1.06(0.32) 
Passive smokers 
removed from the 
referent group 
5 1.13 1.04 ± 1.22 7[0;81] 0.98(0.33) -1.29(0.52) -0.12(0.91) 
Passive smokers 
included in the referent 
group 
26 1.10 1.09 ± 1.12 0[0;37] 0.02(0.98) 1.08(0.21) -0.97(0.34) 
Non-drinkers 3 1.05 0.80 ± 1.37 19[0;92] 1.04(0.3) -0.30(0.88) 0.78(0.58) 
Started smoking before 
20 years old 9 1.11 1.07 ± 1.15 2[0;65] 0.21(0.84) 1.95(0.05) -2.30(0.05) 
Started smoking after 20 
years old 9 1.07 1.05 ± 1.10 0[0;0] 0.21(0.84) 0.11(0.81) -0.04(0.97) 
All 27 1.10 1.09 - 1.12 0[0;34] 0.04(0.97) 1.02 (0.22) -0.96 (0.34) 
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Table 3 Subgroup analyses among prospective studies investigating the association between ever being exposed 
to passive smoking and breast cancer risk 
Subgroup No. of 
studies 
RR 95% CI I2(%) Begg 
(p-value) 
Egger 
(p-value) 
Macaskill 
(p-value) 
Childhood exposure 4 0.99 0.89 ± 1.10 16[0;87] 0.68(0.5) 1.51(0.12) -2.94(0.1) 
Household exposure 6 1.02 0.92 ± 1.13 35[0;74] 0.75(0.45) -1.15(0.06) 1.57(0.19) 
Workplace exposure 3 0.98 0.88 ± 1.10 0[0;84] 1.04(0.3) 1.45(0.79) -3.12(0.2) 
European 3 1.07 0.85 ± 1.35 53[0;86] 1.04(0.3) -1.15(0.87) 0.77(0.58) 
Asian 3 0.99 0.40 ± 2.46 53[0;87] 1.04(0.3) -4.02(0.45) 4.81(0.13) 
North American 5 1.08 1.02 ± 1.15 0[0;41] 0.49(0.63) 1.91(0.04) -0.98(0.4) 
Post-menopausal 6 1.04 0.90 ± 1.21 54[0;81] 0.75(0.45) -0.66(0.76) 0.84(0.45) 
Pre-menopausal 5 1.16 0.62 ± 2.16 73[31;89] 0.98(0.33) -1.33(0.75) -0.40(0.72) 
All 11 1.07 1.02 ± 1.13 1[0;61] 0.23(0.82) 0.33 (0.76) 0.65 (0.53) 
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Figures 
Fig 1 PRISMA search strategy and number of records identified for the association between smoking and breast 
cancer incidence risk  
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Fig 2 Forest plot of all studies for active ever smoking and breast cancer risk. The risk estimate and 95% CI from 
each study are shown by a square and segments, respectively. The overall summary relative risk is represented 
by a rhombus  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 17 
Fig 3 Forest plot of all studies for passive ever smoking and breast cancer risk. The risk estimate and 95% CI 
from each study are shown by a square and segments, respectively. The overall summary relative risk is 
represented by a rhombus  
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Fig 4 Forest plot of prospective studies investigating the association between the duration of ever actively 
VPRNLQJDQGEUHDVWFDQFHUULVN7KHOLQHDUWUHQGVORSHHVWLPDWHȕDQGWKHLU&,IURPHDFKVWXG\DUHVKRZQ
by a square and segments, respectively. The overall summary linear trend slope estimate is represented by a 
UKRPEXV6XPPDU\ȕ6XPPDU\ȕUHSUHVHQWVWKHLQFUHPHQWDOLQFUHDVHLQEUHDVWFDQFHUULVNSHU\HDURIHYHU
active smoking 
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Fig 5 Relative risk of breast cancer incidence in function of the duration of ever actively smoking (in years) 
among 12 studies with prospective designs. The colour of the points indicates the original study and the size of 
the points is inversely proportional to the variance of the RR estimate given in the study. The linear regression 
WUHQGOLQHLVGUDZQLQEODFNXVLQJWKHVXPPDU\VORSHHVWLPDWHȕ DQGWKHGRWWHGOLQHVUHSUHVHQWWKH
confidence interval of the slope estimate 
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ΡΡ: αχτιϖε εϖερ σmοκινγ ανδ ΒΧ ρισκ ιν αλλ στυδιεσ
Ροσενβεργ 1984
Ηιαττ 1986
Βαρον 1986
Στοχκωελλ 1987
ΟΧοννελλ 1987
Ψυαν 1988
Σχηατζκιν 1989
Ροηαν 1989
Χηυ 1990
Παλmερ 1991
Παωλεγα 1992
Φιελδ 1992
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Wακαι 1994
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Ενγελανδ 1996
Βαρον 1996
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Ψανγ 1997
Βοωλιν 1997
ΜχΧρεδιε 1998
Γαmmον 1998
Τυνγ 1999
Ηυανγ 1999
Μανϕερ 2000
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Ζηενγ 2002
Βανδ 2002
ϖανDερΗελ 2003
Ρεψνολδσ 2004
Μανϕερ 2004
Γαmmον 2004
ΑλDελαιmψ 2004
Αλβεργ 2004
ϖανDερΗελ 2005
Σιλλανπαα 2005
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Μεχηανιχ 2006
Λισσοωσκα 2006
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Σωιφτ 2008
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Ζηανγ 2009
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Καυσηαλ 2010
Γιβσον 2010
Ανδονοϖα 2010
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Λυο 2011
Χοξ 2011
Ροσενβεργ 2013
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Γαυδετ 2013
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Πιmηαναm 2014
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Νισηινο 2014
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1.30 [0.60,  2.90]
1.15 [0.62,  2.13]
1.23 [1.05,  1.43]
0.72 [0.61,  0.85]
3.54 [0.73, 17.14]
0.81 [0.45,  1.46]
1.43 [1.03,  1.99]
1.32 [0.84,  2.07]
1.12 [0.96,  1.31]
1.00 [0.91,  1.10]
1.10 [0.97,  1.24]
1.20 [1.02,  1.41]
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1.10 [0.80,  1.50]
1.13 [0.99,  1.30]
1.16 [0.96,  1.41]
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1.37 [0.97,  1.94]
1.02 [0.84,  1.24]
1.00 [0.70,  1.20]
1.03 [0.90,  1.19]
1.12 [0.69,  1.83]
1.11 [0.95,  1.30]
1.20 [1.10,  1.30]
1.20 [0.92,  1.57]
1.03 [0.73,  1.44]
0.76 [0.49,  1.19]
0.85 [0.65,  1.11]
1.17 [1.05,  1.29]
0.92 [0.80,  1.06]
1.12 [0.99,  1.27]
1.10 [0.93,  1.31]
1.09 [1.06, 1.12]
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    382
 724311
  16803
 805769
3005863
    651
   2036
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W(ρανδοm)
4.02%
1.69%
4.25%
0.19%
1.28%
4.18%
0.07%
0.24%
4.11%
3.72%
0.23%
1.15%
3.72%
3.64%
4.14%
0.32%
1.36%
0.09%
0.14%
1.60%
1.45%
0.02%
0.16%
0.47%
0.26%
1.58%
2.76%
2.12%
1.50%
0.99%
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1.07%
2.92%
0.49%
1.84%
0.19%
2.08%
0.46%
0.53%
2.90%
0.38%
1.34%
0.51%
1.88%
1.16%
0.02%
0.40%
1.38%
0.63%
1.56%
0.07%
1.48%
3.70%
1.39%
0.63%
0.42%
0.43%
1.16%
0.67%
1.82%
0.23%
1.56%
3.06%
0.69%
0.44%
0.27%
0.69%
2.56%
1.85%
2.09%
1.38%
Ηετερογενειτψ: Ι″=46%[28; 59], Θ=128.46, δφ=70(π<0.0001)
Πυβλιχατιον βιασ: Βεγγ=0.02(π=0.9802), Εγγερ=0.15(π=0.7099),
Μαχασκιλλ=0.13(π=0.8946)
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Ηιροσε 1995
Μοραβια 1996
ϑοηνσον 2000
Νισηινο 2001
Σηρυβσολε 2004
Γαmmον 2004
Αλβεργ 2004
Σιλλανπαα 2005
Σηαννον 2005
Ηαναοκα 2005
Γραm 2005
Βοννερ 2005
Μεχηανιχ 2006
Λισσοωσκα 2006
Ρολλισον 2008
Πιριε 2008
Λιν 2008
Ζηανγ 2009
Ρεψνολδσ 2009
Αηερν 2009
Ξυε 2011
Λυο 2011
Τανγ 2013
Ροσενβεργ 2013
Ιλιχ 2013
Ηυ 2013
Τονγ 2014
Πιmηαναm 2014
Νισηινο 2014
Ησιεη 2014
Dοσσυσ 2014
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ΡΡ [95% ΧΙ]
1.10 [1.01, 1.20]
3.40 [2.40, 4.90]
1.09 [0.92, 1.28]
2.27 [1.30, 3.98]
1.46 [1.05, 2.03]
1.54 [0.94, 2.52]
1.57 [0.81, 3.03]
1.18 [0.98, 1.42]
1.47 [1.18, 1.83]
1.09 [0.92, 1.29]
1.04 [0.94, 1.16]
0.94 [0.58, 1.52]
1.10 [0.94, 1.30]
1.35 [1.03, 1.77]
1.24 [0.84, 1.85]
0.98 [0.88, 1.09]
1.06 [0.56, 2.02]
1.10 [0.84, 1.45]
1.10 [0.93, 1.31]
1.19 [0.87, 1.61]
1.21 [0.98, 1.50]
1.10 [0.80, 1.60]
0.88 [0.69, 1.15]
0.85 [0.62, 1.16]
1.20 [0.59, 2.40]
1.04 [0.81, 1.35]
1.02 [0.81, 1.29]
0.58 [0.32, 1.10]
1.43 [1.01, 2.02]
3.20 [1.70, 5.90]
1.24 [1.04, 1.49]
1.20 [1.07, 1.33]
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2.11%
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3.51%
2.61%
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1.46%
3.49%
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3.22%
3.97%
2.94%
3.63%
3.18%
1.28%
3.63%
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1.52%
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Ηετερογενειτψ: Ι″=67%[53; 78], Θ=91.85, δφ=30(π<0.0001)
Πυβλιχατιον βιασ: Βεγγ=0.10(π=0.9188), Εγγερ=1.17(π=0.0451),
Μαχασκιλλ=!1.01(π=0.3224)
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Χατσβυργ2014
Λανδ2014
Χατσβυργ2015
Συmmαρψ  β
Στυδψ
β λινεαρ σλοπε
ωιτη 95% ΧΙ
β  [95% ΧΙ]
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Ηετερογενειτψ: Ι″=65%[34; 81], Θ=31.02, δφ=11(π=0.0011)
Πυβλιχατιον βιασ: Βεγγ=0.34(π=0.7317), Εγγερ=2.69(π=0.1552),
Μαχασκιλλ=0.30(π=0.7726)
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